Literature DB >> 12730669

Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis.

Qian-Fei Wang1, Rebecca Cleaves, Tanawan Kummalue, Claus Nerlov, Alan D Friedman.   

Abstract

CCAAT/enhancer binding protein alpha (C/EBPalpha) transactivates target genes dependent upon DNA binding via its basic region-leucine zipper domain and slows G1 progression by interaction with E2F, cdk2, or cdk4. E2F interacts with the non-DNA-binding surface of the C/EBPalpha basic region and C/EBPalpha residues 1-70 are required for repressing E2F targets, while cdk2 and cdk4 bind residues 177-191. C/EBPalpha-ER induces the 32D cl3 myeloblast cell line to differentiate to granulocytes. C/EBPalpha-ER variants incapable of binding DNA slowed G1, but did not induce early or late granulopoiesis, indicating that cell cycle inhibition as mediated by C/EBPalpha is not sufficient for differentiation. C/EBPalpha-ER variants lacking residues 11-70 or residues 11-70 and 178-200 both slowed the G1 to S transition. C/EBPalpha(GZ)-ER, containing the GCN4 rather than the C/EBPalpha leucine zipper, also slowed G1. In contrast, C/EBPalpha(BRM2)-ER, carrying mutations in the outer surface of the basic region required for interaction with E2F, did not slow G1. C/EBPalpha(BRM2)-ER induced early markers of granulopoiesis much less efficiently than C/EBPalpha-ER and did not direct terminal maturation. Inhibition of G1 progression using mimosine increased induction of late markers by G-CSF. Thus, both DNA binding and cell cycle arrest, mediated by opposite surfaces of the C/EBPalpha basic region, are required for granulopoiesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730669     DOI: 10.1038/sj.onc.1206360

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  C/EBPalpha directs monocytic commitment of primary myeloid progenitors.

Authors:  Dehua Wang; Jenice D'Costa; Curt I Civin; Alan D Friedman
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

2.  C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.

Authors:  Christine Yeamans; Dehua Wang; Ido Paz-Priel; Bruce E Torbett; Daniel G Tenen; Alan D Friedman
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

3.  Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Nikolai A Timchenko
Journal:  Exp Cell Res       Date:  2008-02-13       Impact factor: 3.905

4.  Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes.

Authors:  Noemi A Zambetti; Eric M J Bindels; Paulina M H Van Strien; Marijke G Valkhof; Maria N Adisty; Remco M Hoogenboezem; Mathijs A Sanders; Johanna M Rommens; Ivo P Touw; Marc H G P Raaijmakers
Journal:  Haematologica       Date:  2015-07-16       Impact factor: 9.941

5.  Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.

Authors:  J A Pulikkan; V Dengler; A A Peer Zada; A Kawasaki; M Geletu; Z Pasalic; S K Bohlander; A Ryo; D G Tenen; G Behre
Journal:  Leukemia       Date:  2010-04-08       Impact factor: 11.528

6.  CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities.

Authors:  Young-Jin Lee; Letetia C Jones; Nikolai A Timchenko; Danilo Perrotti; Daniel G Tenen; Scott C Kogan
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

7.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.

Authors:  John A Pulikkan; Viola Dengler; Philomina S Peramangalam; Abdul A Peer Zada; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

Review 8.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

9.  Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity.

Authors:  Guo-Li Wang; Polina Iakova; Margie Wilde; Samir Awad; Nikolai A Timchenko
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

Review 10.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.